Fluor (FLR) PT Lowered to $57 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Vertical Research Partners Downgrades Fluor (FLR) to Hold
May 4, 2018 3:32 PM EDTVertical Research Partners downgraded Fluor (NYSE: FLR) from Buy to Hold.
For an analyst ratings summary and ratings history on Fluor click here. For more ratings news on Fluor click here.
Shares of Fluor closed at $58.99 yesterday.
... MoreFluor Corp. (FLR) call put ratio 1 call to 1.8 puts with focus on May 45 and 47.50 puts as shares down 21%
May 4, 2018 10:39 AM EDTFluor Corp. (NYSE: FLR) call put ratio 1 call to 1.8 puts with focus on May 45 and 47.50 puts as shares down 21%
Canaccord Genuity Downgrades Fluor (FLR) to Hold, 'Execution Issues Push Us To The Sidelines'
May 4, 2018 10:29 AM EDTCanaccord Genuity downgraded Fluor (NYSE: FLR) from Buy to Hold with a price target of $52.00 (from $64.00).
For an analyst ratings summary and ratings history on Fluor click here. For more ratings news on Fluor click here.
Shares of Fluor closed at $58.99 yesterday.
... MorePre-Open Stock Movers 05/04: (PTLA) (CVGI) (SHAK) Higher; (IMTE) (FLR) (ANET) Lower (more...)
May 4, 2018 9:09 AM EDTToday's Pre-Open Movers
Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) 29.6% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved Andexxa, the first and only antidote indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled... More
Wall St. rallies as inflation fears ebb; Apple hits record high
May 4, 2018 7:52 AM EDTBy April Joyner
NEW YORK (Reuters) - The three major U.S. stock indexes rose more than 1 percent on Friday after weaker-than-expected U.S. wage growth helped to calm investor fears about rising interest rates and inflation, though the S&P 500 and Dow Industrials still posted losses for the week.
Apple Inc (NASDAQ: AAPL) provided the biggest boost as it jumped to a record high of $184.25 during the session after Warren Buffett's Berkshire Hathaway Inc disclosed that it had raised its stake in the iPhone maker.
Apple shares ended... More
Fluor (FLR) PT Lowered to $69 at Citi
May 4, 2018 6:41 AM EDTCiti lowered its price target on Fluor (NYSE: FLR) to $69.00 (from $75.00) while maintaining a Buy rating.
... MoreFluor (FLR) PT Lowered to $60 at Barclays
May 4, 2018 4:15 AM EDTBarclays lowered its price target on Fluor (NYSE: FLR) to $60.00 (from $64.00) while maintaining a Equalweight rating.
... MoreUPDATE: Baird Downgrades Fluor (FLR) to Neutral
May 4, 2018 2:38 AM EDT(Updated - May 4, 2018 5:31 AM EDT)
(updated to add analyst comment)
Baird downgraded Fluor (NYSE: FLR) from Outperform to Neutral with a price target of $53.00 (from $65.00).
Analyst Andrew Wittmann comments "Our prior thesis centered on early-stage commodity cycle recovery as prior... More
Fluor (FLR) PT Lowered to $52 at DA Davidson
May 4, 2018 1:28 AM EDTDA Davidson lowered its price target on Fluor (NYSE: FLR) to $52.00 (from $63.00) while maintaining a Neutral rating.
... MoreFluor Corp. (FLR) Misses Q1 EPS by 90c, Revenue Beats, Lowers FY EPS Guidance
May 3, 2018 4:22 PM EDTFluor Corp. (NYSE: FLR) reported Q1 EPS of ($0.13), $0.90 worse than the analyst estimate of $0.77. Revenue for the quarter came in at $4.82 billion versus the consensus estimate of $4.72 billion.
Results for the quarter include an after-tax charge of approximately $96 million, or $0.69 per... More
